Literature DB >> 9742894

Bladder cancer: state-of-the-art care.

M J Droller1.   

Abstract

The challenge in bladder cancer is to control superficial disease and prevent its recurrence or progression. Patients with invasive disease need to be identified earlier, when disease may be less advanced and more amenable to cure. An important area for further investigation is the biology of the various forms of bladder cancer and the various pathways of development they may follow.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9742894     DOI: 10.3322/canjclin.48.5.269

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  17 in total

1.  Sandwich ELISA for detecting urinary Survivin in bladder cancer.

Authors:  Xuefeng Li; Yaming Wang; Jianjun Xu; Qingyun Zhang
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

2.  The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer.

Authors:  Norio Nonomura; Yasutomo Nakai; Masashi Nakayama; Hitoshi Inoue; Kazuo Nishimura; Eijirou Hatanaka; Ryouichi Arima; Tomomi Kishimoto; Tsuneharu Miki; Hideya Kuroda; Akihiko Okuyama
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

3.  Soluble HER3 predicts survival in bladder cancer patients.

Authors:  Ashfaque A Memon; Stephen C Gilliver; Michael Borre; Jan Sundquist; Kristina Sundquist; Ebba Nexo; Boe S Sorensen
Journal:  Oncol Lett       Date:  2017-11-22       Impact factor: 2.967

4.  [Urothelial carcinoma of the bladder: evaluation by combined endoscopy and urine cytology: is incontrovertible assessment possible?].

Authors:  J Hess; S Tschirdewahn; T Szarvas; R Rossi; H Rübben; F Vom Dorp
Journal:  Urologe A       Date:  2011-06       Impact factor: 0.639

5.  Changing patterns of bladder cancer in the USA: evidence of heterogeneous disease.

Authors:  Yawei Zhang; Cairong Zhu; Maria Paula Curado; Tongzhang Zheng; Peter Boyle
Journal:  BJU Int       Date:  2011-05-18       Impact factor: 5.588

6.  The influence of post-diuretic late phase imaging in visual and quantitative evaluation of urothelial tumors by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.

Authors:  Zehra Pınar Koç; Pelin Özcan Kara; Emel Sezer; Kadir Eser
Journal:  Turk J Urol       Date:  2019-12-01

7.  Detection of bladder cancer from the urine using fluorescence in situ hybridization technique.

Authors:  Péter Riesz; Gábor Lotz; Csilla Páska; Attila Szendrôi; Attila Majoros; Zsuzsanna Németh; Péter Törzsök; Tibor Szarvas; Ilona Kovalszky; Zsuzsa Schaff; Imre Romics; András Kiss
Journal:  Pathol Oncol Res       Date:  2007-10-07       Impact factor: 3.201

Review 8.  Localized bladder cancer.

Authors:  J I Izawa; H B Grossman
Journal:  Curr Treat Options Oncol       Date:  2000-12

9.  Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.

Authors:  S Wang; Q Li; K Wang; Y Dai; J Yang; S Xue; F Han; Q Zhang; J Liu; W Wu
Journal:  Clin Transl Oncol       Date:  2013-02-14       Impact factor: 3.405

10.  Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer.

Authors:  Sheng Wang; Sheng Xue; Yuanqing Dai; Jianfu Yang; Zhijun Chen; Xiwu Fang; Wensheng Zhou; Wei Wu; Qingwen Li
Journal:  Diagn Pathol       Date:  2012-11-22       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.